Survey reveals COVID-19 challenges to R&D and innovation in South African businesses, indicating need for support mechanisms.
R&D spend is one indicator of the health and resilience of a business. Despite the unprecedented challenge posed by COVID-19, some businesses in South Africa continued to invest in research and development while making tough choices. Equally, businesses with innovation activity-including R&D but also other types of activity-quickly adapted to the challenging context of the global coronavirus pandemic with new coping and survival strategies. A Statistics South Africa business impact survey in 2020 highlighted key trends which remain significant as the country confronts the challenges of COVID-19's second wave. For government policy makers, business leaders, and business support groups concerned to promote R&D and innovation, this fact sheet points to the necessity of national and sector support mechanisms for R&D-performing and innovation-active businesses whose turnover, and very survival, under stringent lockdown conditions are threatened.
No takes yet. Share an insight, caveat, or question.
Human Sciences Research Council (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: